Durbin presses Pfizer, Eli Lilly on telehealth platforms
Sen. Dick Durbin, D-Ill., is questioning two of the largest pharmaceutical companies on their efforts to establish direct-to-consumer telehealth platforms.
To access this content, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users, or log in if you are a member.
